[1] Braun J,Sieper J. Ankylosing spondylitis[J]. Lancet,2007,369(9570):1379-1390. [2] Quaden DH,De Winter LM,Somers V.Detection of novel diagnostic antibodies in ankylosing spondylitis:An overview[J].Autoimmun Rev,2016,15(8):820-832. [3] Stolwijk C,Essers I,van Tubergen A,et al.The epidemiology of extra-articular manifestations in ankylosing spondylitis:a population-based matched cohort study[J].Ann Rheum Dis,2015,74(7):1373-1378. [4] Smith JA.Update on ankylosing spondylitis:current concepts in pathogenesis[J].Curr Allergy Asthma Rep,2015,15(1):489. [5] Exarchou S,Lindström U,Askling J,et al.The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations:a nationwide register study[J].Arthritis Res Ther,2015,17:118. [6] Machado MA,Moura CS,Ferré F,et al.Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis[J].Rev Saude Publica,2016,50:50. [7] Liu KG,He QH,Tan JW,et al.Expression of TNF-α,VEGF,and MMP-3 mRNAs in synovial tissues and their roles in fibroblast-mediated osteogenesis in ankylosing spondylitis[J].Genet Mol Res,2015,14(2):6852-6858. [8] Escudero-Vilaplana V,Ramírez-Herráiz E,Alañón-Plaza E,et al.Efficiency of adalimumab,etanercept and infliximab in ankylosing spondylitis in clinical practice[J].Int J Clin Pharm,2015,37(5):808-814. [9] Bollow M,Braun J,Taupitz M,et al.CT guided intraarticular corticosteroid injection into the sacroiliac joints in patients with spondyloarthropathy:Indication and follow-up with contrast-enhanced MRI[J].JComput Assist Tomogr,1996,20(4):512-521. [10] 欧阳苏珊,王高亚,李敏,等.骨盆正位像评价强直性脊柱炎髋关节病变临床意义研究[J].中国实用内科杂志,2017,7(6):537-539. [11] Akkoç N,Yarkan H,Kenar G,et al.Ankylosing spondylitis:HLA-B*27-positive versus HLA-B*27-negative disease[J].Curr Rheumatol Rep,2017,19(5):26. [12] Ranganathan V,Gracey E,Brown MA,et al.Pathogenesis of ankylosing spondylitis-recent advances and future directions[J].Nat Rev Rheumatol,2017,13(6):359-367. [13] Prince DS,McGuigan LE,McGirr EE.Working life and physical activity in ankylosing spondylitis pre and post anti-tumor necrosis factor-alpha therapy[J].Int J Rheum Dis,2014,17(2):165-172. [14] Maxwell LJ,Zochling J,Boonen A,et al.TNF-alpha inhibitors for ankylosing spondylitis[J].Cochrane Database Syst Rev,2015,4(4):CD005468. [15] Poddubnyy DA,Song IH,Sieper J.The safety of celecoxib in ankylosing spondylitis treatment[J].Expert Opin Drug Saf,2008,7(4):401-409. [16] Joshi N,Nautiyal A,Walton T.Infliximab therapy for inflammatory discitis in ankylosing spondylitis[J].J Clin Rheumatol,2012,18(2):109-110. |